An exploratory behavioral intervention trial to improve rates of screening for AIDS clinical trials among racial/ethnic minority and female persons living with HIV/AIDS

Marya Viorst Gwadz, Keith Cylar, Noelle R. Leonard, Marion Riedel, Nina Herzog, Gricel N. Arredondo, Charles M. Cleland, Michael Aguirre, Ann Marshak, Donna Mildvan

Research output: Contribution to journalArticlepeer-review

Abstract

Individuals from racial/ethnic minority backgrounds and women have not been proportionately represented in AIDS clinical trials (ACTs). There have been few intervention efforts to eliminate this health disparity. This paper reports on a brief behavioral intervention to increase rates of screening for ACTs in these groups. The study was exploratory and used a single-group pre/ posttest design. A total of 580 persons living with HIV/ AIDS (PLHA) were recruited (39% female; 56% African-American, 32% Latino/Hispanic). The intervention was efficacious: 25% attended screening. We identified the primary junctures where PLHA are lost in the screening process. Both group intervention sessions and an individual contact were associated with screening. Findings provide preliminary support for the intervention's efficacy and the utility of combining group and individual intervention formats. Interventions of greater duration and intensity, and which address multiple levels of influence (e.g., social, structural), may be needed to increase screening rates further.

Original languageEnglish (US)
Pages (from-to)639-648
Number of pages10
JournalAIDS and Behavior
Volume14
Issue number3
DOIs
StatePublished - Jun 2010

Keywords

  • Behavioral intervention
  • Gender disparities
  • HIV/AIDS clinical trials
  • Motivational interviewing
  • Racial/ethnic disparities
  • Screening

ASJC Scopus subject areas

  • Social Psychology
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Fingerprint Dive into the research topics of 'An exploratory behavioral intervention trial to improve rates of screening for AIDS clinical trials among racial/ethnic minority and female persons living with HIV/AIDS'. Together they form a unique fingerprint.

Cite this